Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)
1 clinical trials · Condition
◉ Watch Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)
| Record | Firm | Date |
|---|---|---|
| Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) (NCT03581942) | Memorial Sloan Kettering Cancer Center | 2018-08-23 |
Track Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) automatically
Every clearance here is in the API, with alerts when new ones post.